ABBV-444

DRUG2 trials

Sponsors

AbbVie

Conditions

Dry Eye DiseaseDry Eye Syndrome

Phase 3

A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants

CompletedNCT05878067

AbbVieDry Eye Syndrome

Start: 2023-06-27End: 2023-10-06Updated: 2024-10-15

A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease

CompletedNCT07284381

AbbVieDry Eye Disease

Start: 2025-12-15End: 2026-08-21Updated: 2026-09-17